MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.17272

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2022

Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.

Wang Jian, Yan Xiaomin, Zhu Li, Liu Jiacheng, Qiu Yuanwang, Li Yiguang, Liu Yilin, Xue Ruifei, Zhan Jie, Jiang Suling, Geng Yu, Wan Yawen, Li Ming, Mao Minxin, Gao Dongmei, Yin Shengxia, Tong Xin, Xia Juan, Ding Weimao, Chen Yuxin, Li Jie, Zhu Chuanwu, Huang Rui, Wu Chao

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Many patients with chronic hepatitis B (CHB) do not meet the definitions of the traditional natural phases and are classified as being in the grey zone (GZ).

AIMS: To investigate liver histology, and to establish a management strategy for patients with CHB in the GZ.

METHODS

This study included 1043 patients with CHB who underwent liver biopsy. Phases of natural history were determined according to the AASLD 2018 hepatitis B guidance. CHB patients in the GZ were divided into HBeAg-positive, normal ALT and HBV DNA ≤106  IU/ml (GZ-A); HBeAg-positive, elevated ALT and HBV DNA ≤2 × 104  IU/ml (GZ-B); HBeAg-negative, normal ALT and HBV DNA ≥2 × 103  IU/ml (GZ-C) and HBeAg-negative, elevated ALT and HBV DNA ≤2 × 103  IU/ml (GZ-D). Significant histological disease was defined as liver inflammation ≥G2 and/or liver fibrosis ≥S2.

RESULTS

Two hundred and forty two (23.2%) patients were in the GZ. Approximately 72.7% had significant histological disease. HBeAg-positive GZ CHB patients had a higher proportion of significant histological disease than HBeAg-negative GZ patients (91.1% vs. 68.5%, p = 0.002). GZ-D (42.6%) was the dominant category, followed by GZ-C (38.8%), GZ-A (10.3%) and GZ-B (8.3%). The highest proportion of significant histological disease was observed patients in GZ-B (100.0%), followed by GZ-A (84.0%), GZ-D (69.9%) and GZ-C (67.0%). Prothrombin time (PT) was an independent risk factor of significant histological disease in the HBeAg-negative GZ.

CONCLUSIONS

Over 70% of GZ CHB patients had significant histological disease. We recommend antiviral treatment for HBeAg-positive and HBeAg-negative GZ CHB patients with high PT.

Для цитирования: Wang Jian, Yan Xiaomin, Zhu Li, Liu Jiacheng, Qiu Yuanwang, Li Yiguang, Liu Yilin, Xue Ruifei, Zhan Jie, Jiang Suling, Geng Yu, Wan Yawen, Li Ming, Mao Minxin, Gao Dongmei, Yin Shengxia, Tong Xin, Xia Juan, Ding Weimao, Chen Yuxin, Li Jie, Zhu Chuanwu, Huang Rui, Wu Chao. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.. Alimentary pharmacology & therapeutics. 2022. DOI: 10.1111/apt.17272.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.